Acenxion Biosystems

Developer of phenotypic AST devices forcandidate antibiotic or precision patient treatment

placeKansas City, Kansas, United States calendar_todayFounded 2020 groups10 employees language acenxionbiosystems.com

Innovation

2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 16 times.

YearFilings
20221
20232
20241

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon